OTC Weight Loss Pills: What Actually Works? (2026 Evidence Review)

Key Takeaways

We went through the pooled trial data for the OTC drug and eight popular supplements. Alli works, modestly, and its side effects come from the way it works. L-carnitine, chitosan, berberine and garcinia each add somewhere between 0.9 and 1.2 kg in meta-analyses. Glucomannan and green tea extract show no reliable effect outside a few trial settings. Garcinia carries a documented liver risk, and the FDA warns that many diet pills contain hidden drugs. People already on a GLP-1 medication have a different problem to solve, which is getting enough nutrients while eating much less.

Do any OTC weight loss pills actually work?

One does, with FDA approval behind it: orlistat 60 mg, sold as Alli (FDA, via HealthDay). Everything else on the shelf is a dietary supplement, and the FDA does not approve supplements for any purpose or review them before they are sold (FDA). A few supplements show small effects in meta-analyses, typically around a kilogram.

The phrase "OTC weight loss pill" covers two very different kinds of product. Orlistat went through drug approval, which meant controlled trials and an FDA advisory committee review before it reached pharmacy shelves in 2007 (FDA, via HealthDay). Supplements reach shelves under different rules. The manufacturer is responsible for safety and accurate labeling, and the FDA's role mostly begins after the product is already for sale (FDA).

So a supplement bottle that says "clinically studied" may be pointing to a single small trial, a trial of a different dose, or no trial at all. The only reliable way to judge one is to look at what pooled, placebo-controlled trials found. We built the comparison below the same way. Each bar shows how much more weight people lost than the placebo group in the best available analysis, and trial lengths differ, so read it as a ranking rather than a precise forecast.

How well does Alli (orlistat 60 mg) work?

Modestly. In a 16-week placebo-controlled trial of mildly to moderately overweight adults, people on orlistat 60 mg lost 3.05 kg and people on placebo lost 1.90 kg, both while following a reduced-calorie diet (Anderson et al., 2006). Stomach and bowel side effects were more common with the drug.

Orlistat blocks lipase, the gut enzyme that breaks down fat, so part of the fat in a meal passes through undigested. Dose-finding studies showed that at full effect about 32% of dietary fat ends up in the stool, compared with 5% on placebo, and half of that maximum is reached at roughly 98 mg a day (Zhi et al., 1994). Alli is taken as one 60 mg capsule with each fat-containing meal, up to three times a day (FDA, via HealthDay). GSK, the original manufacturer, describes this as blocking about a quarter of dietary fat (GSK press release).

The prescription version, Xenical, is twice the dose. Its best-known trial, XENDOS, followed 3,305 adults with obesity for four years (Torgerson et al., 2004). People on orlistat 120 mg lost 5.8 kg against 3.0 kg on placebo, and their rate of new type 2 diabetes was 6.2% against 9.0% (Torgerson et al., 2004). Staying on the drug was hard. Only 52% of the orlistat group finished the four years, against 34% of the placebo group (Torgerson et al., 2004).

The side effects are mechanical. Unabsorbed fat has to leave somehow. It shows up as oily stools, urgency and gas, and a high-fat meal makes all of it worse. Orlistat also reduces absorption of fat-soluble vitamins. The FDA advised Alli users to take a multivitamin at bedtime when it approved the drug (FDA, via HealthDay). Even that may not cover everything: in adolescents taking orlistat, vitamin D levels fell within a month despite a daily multivitamin (McDuffie et al., 2002).

Alli is not for everyone. Some people should skip it entirely. People who have had an organ transplant should not take it, according to the FDA, and anyone on blood thinners or being treated for diabetes or a thyroid condition should talk to a doctor first (FDA, via HealthDay).

Which weight loss supplements have the strongest evidence?

L-carnitine has the largest pooled effect, at 1.21 kg across 37 trials (Talenezhad et al., 2020). Chitosan (Huang 2020), berberine (Elahi Vahed 2026) and garcinia (Onakpoya 2011) sit just under 0.9 kg. CLA adds about a third of a kilogram. Glucomannan and green tea extract did not beat placebo in the main meta-analyses.

The table summarizes the strongest pooled analysis we could find for each ingredient. "Extra weight loss" means the average difference from placebo, not the total amount people lost.

Why do pooled effects look so small? Partly because the trials are short. Most run 8 to 16 weeks, while weight loss medicine is judged over a year or more. Partly because the people in placebo groups also diet, so the comparison isolates only what the pill adds. A joint advisory from four obesity and nutrition societies put prescription GLP-1 weight loss at 5 to 18% in trials (Mozaffarian et al., 2025). Nothing in the table gets near that.

A pattern runs through the whole list. The effects are real in a statistical sense, because pooling dozens of trials gives enough power to detect them, but they are small next to what a sustained calorie deficit does on its own. None of these supplements changes the basic arithmetic of weight loss. We have separate evidence reviews on magnesium, creatine and shilajit for weight loss.

L-carnitine

L-carnitine carries fatty acids into mitochondria to be burned for energy. The 2020 meta-analysis pooled 37 randomized trials with 2,292 participants and found 1.21 kg of extra weight loss and 2.08 kg less fat mass than placebo (Talenezhad et al., 2020). The effect leveled off at about 2,000 mg a day and was clearest in adults who were already overweight; waist circumference did not change (Talenezhad et al., 2020).

Chitosan

Chitosan is a fiber made from shellfish shells that binds some dietary fat in the gut. Across 15 trials and 1,130 people it added 0.89 kg of weight loss, with better results at doses above 2.4 g a day and in trials shorter than 12 weeks (Huang et al., 2020). The authors called the evidence conclusive. Conclusive and large are different things, though. People with shellfish allergies should check the source before taking it.

Berberine

Berberine is a plant alkaloid best known for its effects on blood sugar. A 2026 meta-analysis of 23 studies found an average weight reduction of 0.88 kg and a BMI drop of 0.48 points compared with control groups (Elahi Vahed et al., 2026). The authors flagged weak reporting on product purity and dose in many of the trials. Our full berberine weight loss review goes through those studies one by one.

Garcinia cambogia (hydroxycitric acid)

On paper, garcinia looks no different: 0.88 kg across nine trials, with the authors calling the clinical relevance uncertain (Onakpoya et al., 2011). Its safety record is another matter. More on that below.

CLA (conjugated linoleic acid)

CLA has one of the largest evidence bases of any weight loss supplement. A 2024 meta-analysis covered 70 randomized trials and 4,159 adults (Asbaghi et al., 2024). It reduced body weight by 0.35 kg and fat mass by 0.44 kg (Asbaghi et al., 2024). Those numbers are statistically solid and practically small.

Glucomannan

Glucomannan, a fiber from the konjac root, absorbs water and swells in the stomach. The two main meta-analyses disagree. A 2008 analysis of 14 studies found 0.79 kg of extra weight loss (Sood et al., 2008). A stricter 2014 analysis limited to eight randomized trials found 0.22 kg, which was not statistically significant (Onakpoya et al., 2014). Newer work, a 2026 systematic review, found that glucomannan does seem to increase fullness, but several human studies still reported no effect on weight (Kusuma et al., 2026).

Green tea extract

A Cochrane review split green tea trials by location because the results were so different. Six trials outside Japan, with 532 participants, found a difference of 0.04 kg, which is effectively zero (Jurgens et al., 2012). Eight Japanese trials reported losses between 0.2 and 3.5 kg, but they were too inconsistent to pool (Jurgens et al., 2012). The reviewers concluded the effect is small and probably not clinically important.

Does apple cider vinegar help with weight loss?

Maybe, a little, for a while. A 2025 meta-analysis of 10 randomized trials with 789 participants found that daily apple cider vinegar reduced body weight and BMI compared with control, and trimmed waist size too, with the clearest effects at about 30 mL a day for up to 12 weeks (Castagna et al., 2025). The analysis reported a standardized effect rather than kilograms, so the real-world size is hard to state.

The benefit showed up mainly in adults with excess weight or type 2 diabetes (Castagna et al., 2025). Studies with a high risk of bias were removed in a sensitivity check and the result held. This is more encouraging than most of the list. The trials were short, though, and the dose was a measured amount of liquid vinegar, not a capsule or gummy.

An earlier safety review found that the risk of side effects at recommended amounts seemed low, while warning that the evidence for health effects was still thin (Launholt et al., 2020). Undiluted vinegar is acidic, so it should be diluted in water.

Is L-carnitine worth taking for weight loss?

It has the best pooled result of any supplement we reviewed, at 1.21 kg of extra weight loss, and the effect held when the analysis was limited to high-quality trials (Talenezhad et al., 2020). That still means about a kilogram over the length of a typical trial.

Benefits peaked around 2,000 mg a day in the same analysis, so higher doses are unlikely to help more. Fat mass fell by 2.08 kg, a little more than total weight (Talenezhad et al., 2020). That hints at a small shift in body composition. Body fat percentage and waist circumference did not change significantly, which is a reminder of how modest the effect is.

Which weight loss supplements carry real risks?

Garcinia is the clearest example: a 2025 review identified more than 200 reports of liver injury, including one death and nine liver transplants (van Breemen et al., 2025). Concentrated green tea extract can also harm the liver at high bolus doses. The broader risk is contamination: the FDA says many diet and fat-burning pills are likely to contain hidden drug ingredients (FDA).

The garcinia review looked at 34 detailed case reports. Seventeen had causality scores ranging from possible to highly probable, and one case was confirmed when the patient took garcinia again and the liver injury returned (van Breemen et al., 2025). The proposed mechanisms include an immune reaction tied to a specific genetic variant, which would explain why most users are fine and a few are badly hurt.

Green tea's liver problems follow the dose. A systematic review of toxicology and 159 human intervention studies found liver side effects mainly with concentrated, catechin-rich extracts taken as large single doses, not with brewed tea, and proposed a safe intake of 338 mg of EGCG a day for adults (Hu et al., 2018). One of that review's authors worked for a supplement company, which is worth knowing when reading the safe-intake figure.

Contamination is the risk you cannot see on the label. A 2026 systematic review of 44 studies found that roughly 9 to 15% of tested supplements contained prohibited substances or undeclared drugs, most often in pre-workout, weight loss and muscle-building products (Al-Saad et al., 2026). A running federal list tracks weight loss products found to contain hidden ingredients (FDA).

How do OTC pills compare with prescription weight loss pills?

The gap is huge. In the OASIS 4 trial, the Wegovy pill (oral semaglutide 25 mg) produced 13.6% body weight loss at 64 weeks against 2.2% on placebo (Wharton et al., 2025). Novo Nordisk puts the average starting weight in that trial at 235 lb, so the placebo-adjusted difference works out to roughly 12 kg (Novo Nordisk). Alli's added effect in its main OTC trial was about 1 kg (Anderson et al., 2006).

Regulators approved the Wegovy pill on December 22, 2025, for adults with obesity, or with overweight plus a weight-related medical problem, alongside diet and exercise (Novo Nordisk). It requires a prescription. Self-pay pricing starts at $149 a month for the lowest dose and reaches $299 for the highest (Novo Nordisk). Our comparison of GLP-1 drugs for weight loss covers the injectable options too.

More weight loss came with more side effects. Gastrointestinal problems affected 74.0% of people on the Wegovy pill against 42.2% on placebo (Wharton et al., 2025). Hence the medical follow-up, and hence the side effect profile of GLP-1 drugs matters when deciding between options. The chart below is a rough guide to where each option fits.

Is there an OTC appetite suppressant that works?

Nothing sold over the counter comes close to prescription GLP-1 drugs. Semaglutide cut total daily food intake by 24% in a 12-week study (Blundell et al., 2017). Glucomannan raises fullness in some studies but has not produced reliable weight loss (Onakpoya et al., 2014).

Glucomannan is the obvious OTC candidate for appetite control, since it thickens in the stomach. The 2026 review found its effects on fullness were tied to that viscosity, while resistant starch worked more through gut fermentation (Kusuma et al., 2026). Feeling full and losing weight turned out to be different outcomes. Several human studies saw the first without the second.

Caffeine is the active ingredient in most products sold as appetite suppressants or fat burners. A meta-analysis of 13 randomized trials found that doubling caffeine intake was associated with 22% more weight reduction, but the trials were small and the results varied so much between them that the estimate is shaky (Tabrizi et al., 2019).

Protein is the most reliable appetite tool that does not come in a pill bottle. Reviews of controlled feeding studies found that higher-protein diets, around 1.2 to 1.6 g per kilogram of body weight a day with roughly 25 to 30 g at each meal, improved appetite and weight management, provided people actually stuck to them (Leidy et al., 2015).

What should people on GLP-1 medications take instead?

Weight loss pills make little sense on top of a GLP-1 drug. The more pressing issue is nutrition: a 2026 review covering 480,825 adults found that more than 60% of GLP-1 users ate less calcium and iron than they needed, and vitamin D deficiency rose from 7.5% at six months to 13.6% at twelve (Urbina et al., 2026).

Ferritin, a marker of iron stores, ran 26 to 30% lower in GLP-1 users than in people on SGLT2 inhibitors, and thiamine and B12 shortfalls grew over time (Urbina et al., 2026). Most of the data came from observational studies, so the review could not prove the drugs caused the deficiencies. A joint advisory from four US obesity and nutrition societies listed nutrient deficiencies and loss of muscle and bone among the main challenges of GLP-1 treatment, and called for preventing deficiencies as part of care (Mozaffarian et al., 2025).

In practice that means eating enough protein to protect muscle, watching iron, vitamin D, calcium and B vitamins, and getting labs checked if fatigue or hair loss shows up. Our guide to supplements for GLP-1 users goes nutrient by nutrient, and the muscle loss guide covers protein targets. We also make a GLP-1 Companion Supplement for people who want these nutrients in one product. It is nutritional support, not a weight loss pill, and you should check with the prescriber managing your GLP-1 treatment before adding anything.

Why do so many weight loss pill reviews sound so positive?

Some are fake. In August 2024 the FTC finalized a rule banning fake reviews and testimonials, including AI-generated ones, and allowing civil penalties against businesses that knowingly use them (FTC). Weight loss products have long been a target for this kind of marketing.

The rule also covers reviews written by company insiders without disclosure and fake social media indicators such as bought followers or views (FTC). A rule is not the same as enforcement, though. A useful habit is to compare a product's claims with the trial numbers in this article. A supplement promising 10 kg in a month is promising far more than any meta-analysis in this article found.

A disclosure of our own: we sell supplements, including one designed for people on GLP-1 medications. None of our products are weight loss pills, and nothing in this article ranks them.

How should you approach OTC weight loss pills safely?

Start with the evidence and your health history, not the marketing. The FDA advises talking to a doctor, pharmacist or other health professional before starting any supplement, because supplements can carry risks and interact with medications (FDA). For Alli, follow the label and the FDA's multivitamin advice.

A few practical checks cut most of the risk. Look for single-ingredient products with clear doses, since proprietary blends make it impossible to compare a product with trial data. Prefer brands that publish third-party test results for each batch. Avoid anything sold with prescription-drug language, because those are the products the FDA most often finds tainted (FDA). Stop any product that causes dark urine, yellowing skin or eyes, or a racing heart. Anyone can report a bad reaction to a supplement through the FDA's Safety Reporting Portal, and those reports are how unsafe products get flagged (FDA).

Be realistic about the payoff. It is small. The best results in this article sit around a kilogram over several months. That can be a useful nudge alongside better eating and more movement. It will not substitute for them. For anyone whose weight is causing health problems, a conversation with a doctor about prescription options is a better use of time than cycling through supplements. Those interested in supporting the body's own hormone signals can read about natural ways to support GLP-1.

Frequently Asked Questions

References

1. Anderson JW, Schwartz SM, Hauptman J, et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial. Ann Pharmacother. 2006;40(10):1717-1723.
2. Zhi J, Melia AT, Guerciolini R, et al. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther. 1994;56(1):82-85.
3. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care. 2004;27(1):155-161.
4. McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002;22(7):814-822.
5. Talenezhad N, Mohammadi M, Ramezani-Jolfaie N, Mozaffari-Khosravi H, Salehi-Abargouei A. Effects of l-carnitine supplementation on weight loss and body composition: a systematic review and meta-analysis. Clin Nutr ESPEN. 2020;37:9-23.
6. Huang H, Liao D, Zou Y, Chi H. The effects of chitosan supplementation on body weight and body composition: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020;60(11):1815-1825.
7. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53-73.
8. Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis. J Obes. 2011;2011:509038.
9. Asbaghi O, Shimi G, Hosseini Oskouie F, et al. The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis. Br J Nutr. 2024;131(3):406-428.
10. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis. J Am Coll Nutr. 2014;33(1):70-78.
11. Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr. 2008;88(4):1167-1175.
12. Kusuma RA, Budiono I, Natasyaesa IA, et al. Glucomannan and resistant starch in obesity management: a systematic review. Food Funct. 2026.
13. Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev. 2012;12:CD008650.
14. Castagna A, et al. Effect of apple cider vinegar intake on body composition in humans with type 2 diabetes and/or overweight: a systematic review and meta-analysis. Nutrients. 2025;17(18):3000.
15. Launholt TL, Kristiansen CB, Hjorth P. Safety and side effects of apple vinegar intake and its effect on metabolic parameters and body weight: a systematic review. Eur J Nutr. 2020;59(6):2273-2289.
16. van Breemen RB, et al. Hepatotoxicity of dietary supplements containing Garcinia gummi-gutta. Pharm Biol. 2025.
17. Hu J, Webster D, Cao J, Shao A. The safety of green tea and green tea extract consumption in adults: results of a systematic review. Regul Toxicol Pharmacol. 2018;95:412-433.
18. Al-Saad N, et al. Systematic review of undeclared prohibited substances and pharmacological adulterants in dietary supplements. Front Sports Act Living. 2026.
19. Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity. N Engl J Med. 2025;393:1077-1087.
20. Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242-1251.
21. Tabrizi R, Saneei P, Lankarani KB, et al. The effects of caffeine intake on weight loss: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019;59(16):2688-2696.
22. Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015;101(6):1320S-1329S.
23. Urbina J, et al. Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review. Clin Obes. 2026.
24. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory. Obes Pillars. 2025.
25. U.S. Food and Drug Administration. Facts about dietary supplements.
26. U.S. Food and Drug Administration. Weight loss product notifications.
27. HealthDay. Orlistat approved for over-the-counter sale (FDA announcement). February 7, 2007.
28. Novo Nordisk. Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America. January 5, 2026.
29. Federal Trade Commission. FTC announces final rule banning fake reviews and testimonials. August 2024.